|
67 Companies |
|
98 Products |
|
98 Products |
|
94 Mechanisms of Action |
|
2 Trials |
|
2243 News |
|
| «12345678910111213...4445» |
- | Trial completion, Enrollment change, Trial primary completion date: Evaluation of Intra-Abdominal Fat in Patients With Type 2 Diabetes Using a Non-Invasive Method (clinicaltrials.gov) - Mar 1, 2017
P=N/A, N=110, Completed, Sponsor: Joslin Diabetes Center
Enrolling by invitation --> Completed | N=500 --> 110 | Trial primary completion date: Jun 2017 --> Jan 2017
- | Trial primary completion date: Specially Designed Eating Plates Effects on Food Intake in Normal Weight and Overweight Children (clinicaltrials.gov) - Mar 1, 2017
P=N/A, N=80, Recruiting, Sponsor: Dan Nemet, MD
Enrolling by invitation --> Completed | N=500 --> 110 | Trial primary completion date: Jun 2017 --> Jan 2017 Trial primary completion date: Dec 2016 --> Dec 2017
- | Trial primary completion date: "Neuroband": Enhancement of Brain Circuit of Inhibitory Control in Obese Patients Undergoing Gastric Banding (clinicaltrials.gov) - Feb 27, 2017
P2, N=14, Active, not recruiting, Sponsor: Beth Israel Deaconess Medical Center
Trial primary completion date: Dec 2016 --> Dec 2017 Trial primary completion date: Feb 2017 --> Jul 2017
- | Trial completion: FLOW: Family Lifestyle Overweight Prevention Program (clinicaltrials.gov) - Feb 24, 2017
P3, N=100, Completed, Sponsor: Baylor College of Medicine
Trial primary completion date: Feb 2017 --> Jul 2017 Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: The Effect of Exercise on Hepatic Glucose Metabolism (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=20, Completed, Sponsor: Vanderbilt University
Active, not recruiting --> Completed Enrolling by invitation --> Completed | N=68 --> 20 | Trial primary completion date: Dec 2015 --> Sep 2016
- | Trial completion, Surgery, Bariatric surgery: FORBES: Study of Sleeve Gastrectomy on Iron Intestinal Absorption in Morbidly Obese Patients (clinicaltrials.gov) - Feb 23, 2017
P=N/A, N=88, Completed, Sponsor: Assistance Publique - H
Enrolling by invitation --> Completed | N=68 --> 20 | Trial primary completion date: Dec 2015 --> Sep 2016 Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Gastric Plication and Banding (clinicaltrials.gov) - Feb 20, 2017
P2, N=17, Completed, Sponsor: Ohio State University
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=100 --> 17
- | Trial primary completion date: Effect of DPP4 Inhibition on Growth Hormone Secretion (clinicaltrials.gov) - Feb 17, 2017
P4, N=43, Active, not recruiting, Sponsor: Vanderbilt University
Active, not recruiting --> Completed | N=100 --> 17 Trial primary completion date: Jan 2017 --> May 2017
- Trial primary completion date: The Colorado LEAP Study: A Socioecological Approach to Obesity Prevention in Early Childhood (clinicaltrials.gov) - Feb 15, 2017
P=N/A, N=230, Active, not recruiting, Sponsor: Colorado State University
Trial primary completion date: Jan 2017 --> May 2017 Trial primary completion date: Jun 2015 --> Jul 2017
- galantamine extended release / Generic mfg.
Trial completion: GALANTA-MS: Galantamine Effects in Patients With Metabolic Syndrome (clinicaltrials.gov) - Feb 15, 2017
P4, N=60, Completed, Sponsor: University of Sao Paulo
Trial primary completion date: Jun 2015 --> Jul 2017 Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: VACOPP: Vaasa Childhood Obesity Primary Prevention Study (clinicaltrials.gov) - Feb 14, 2017
P=N/A, N=185, Completed, Sponsor: University of Tampere
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Jan 2017
- | Trial completion, Enrollment change: Obesity and Asthma: Nutrigenetic Response to Omega-3 Fatty Acids (clinicaltrials.gov) - Feb 13, 2017
P2/3, N=144, Completed, Sponsor: Nemours Children's Clinic
Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Jan 2017 Recruiting --> Completed | N=100 --> 144
- Trial completion, Enrollment change: AIMMY: Assessing Inherited Markers of Metabolic Syndrome in the Young (clinicaltrials.gov) - Feb 11, 2017
P=N/A, N=700, Completed, Sponsor: Eric Hoffman
Recruiting --> Completed | N=100 --> 144 Active, not recruiting --> Completed | N=1500 --> 700
- Trial completion, Phase classification, Trial primary completion date: Evaluation of a Family-based Pediatric Obesity Program: TEENS+ (clinicaltrials.gov) - Feb 10, 2017
P=N/A, N=25, Completed, Sponsor: Virginia Commonwealth University
Active, not recruiting --> Completed | N=1500 --> 700 Active, not recruiting --> Completed | Phase classification: P1 --> PN/A | Trial primary completion date: Jan 2020 --> Sep 2016
- Trial completion, Enrollment change, Surgery, Bariatric surgery: Bariatric Surgery and Reactive Hypoglycemia (clinicaltrials.gov) - Feb 7, 2017
P=N/A, N=120, Completed, Sponsor: Catholic University of the Sacred Heart
Active, not recruiting --> Completed | Phase classification: P1 --> PN/A | Trial primary completion date: Jan 2020 --> Sep 2016 Active, not recruiting --> Completed | N=50 --> 120
- ||| Trial completion: PROKA: The Effect of Protein and Calcium on Weight Change and Blood Lipid Profile (clinicaltrials.gov) - Feb 7, 2017
P=N/A, N=223, Completed, Sponsor: University of Copenhagen
Active, not recruiting --> Completed | N=50 --> 120 Active, not recruiting --> Completed
- Aphthasol (amlexanox) / Abeona Therap, Esteve
Clinical protocol, Trial completion: Efficacy of Amlexanox vs. Placebo in Type 2 Diabetic Patients (clinicaltrials.gov) - Feb 7, 2017
P2, N=42, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, Trial primary completion date: The Role of the Omentum in the Treatment of Morbid Obesity (clinicaltrials.gov) - Feb 1, 2017
P=N/A, N=66, Completed, Sponsor: Vanderbilt University Medical Center
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Oct 2011
- Trial primary completion date: Exercise Intolerance in Elderly Patients With Diastolic Heart Failure (clinicaltrials.gov) - Feb 1, 2017
P=N/A, N=100, Active, not recruiting, Sponsor: Wake Forest University
Active, not recruiting --> Completed | Trial primary completion date: Dec 2016 --> Oct 2011 Trial primary completion date: Dec 2016 --> Dec 2017
- Trial completion, Enrollment change, Trial primary completion date: RYGB and the Gastric Adipose Axis (clinicaltrials.gov) - Jan 31, 2017
P1, N=49, Completed, Sponsor: Vanderbilt University
Trial primary completion date: Dec 2016 --> Dec 2017 Enrolling by invitation --> Completed | N=66 --> 49 | Trial primary completion date: Dec 2016 --> Jul 2015
- Trial completion, Phase classification, Enrollment change: Development of Melt Organic Baking Fat for Reducing Child Obesity (clinicaltrials.gov) - Jan 31, 2017
P=N/A, N=15, Completed, Sponsor: Columbia University
Enrolling by invitation --> Completed | N=66 --> 49 | Trial primary completion date: Dec 2016 --> Jul 2015 Recruiting --> Completed | Phase classification: P2 --> PN/A | N=30 --> 15
- |||| Trial primary completion date, Bariatric surgery: Comparison of Laparoscopic Sleeve Gastrectomy and Roux-Y-gastric Bypass in the Treatment of Morbid Obesity (clinicaltrials.gov) - Jan 24, 2017
P3, N=200, Enrolling by invitation, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Completed | Phase classification: P2 --> PN/A | N=30 --> 15 Trial primary completion date: Dec 2016 --> Aug 2017
- ||| Trial completion: HERO Study: Helping Evaluate Reduction in Obesity (clinicaltrials.gov) - Jan 24, 2017
P=N/A, N=1106, Completed, Sponsor: Apollo Endosurgery, Inc.
Trial primary completion date: Dec 2016 --> Aug 2017 Active, not recruiting --> Completed
- Enrollment change, Trial withdrawal: Intraoperative Goal-directed Fluid Management (clinicaltrials.gov) - Jan 23, 2017
P=N/A, N=0, Withdrawn, Sponsor: The Cleveland Clinic
Active, not recruiting --> Completed N=100 --> 0 | Terminated --> Withdrawn
- Trial completion, Phase classification, Trial primary completion date, Surgery, Bariatric surgery: Ghrelin and Insulin Resistance (clinicaltrials.gov) - Jan 23, 2017
P1, N=20, Completed, Sponsor: Vanderbilt University Medical Center
N=100 --> 0 | Terminated --> Withdrawn Active, not recruiting --> Completed | Phase classification: PN/A --> P1 | Trial primary completion date: Dec 2016 --> May 2014
- Enrollment change, Trial termination, Trial primary completion date: Factors Involved in Obesity-related Inflammation and Insulin Resistance (clinicaltrials.gov) - Jan 23, 2017
P=N/A, N=62, Terminated, Sponsor: Vanderbilt University
Active, not recruiting --> Completed | Phase classification: PN/A --> P1 | Trial primary completion date: Dec 2016 --> May 2014 N=120 --> 62 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Jan 2014
- Trial completion, Enrollment change, Trial primary completion date: Study to Evaluate the Health and Wellness Policies of the New Haven Public School District. (clinicaltrials.gov) - Jan 19, 2017
P=N/A, N=796, Completed, Sponsor: Yale University
N=120 --> 62 | Active, not recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Jan 2014 Recruiting --> Completed | N=1100 --> 796 | Trial primary completion date: Aug 2015 --> Jun 2016
- tilarginine (L-NMMA) / Arginox Pharma, Houston Methodist Research Institute
Phase classification: Pathophysiology of Cardiometabolic Risk Factors in African Americans (clinicaltrials.gov) - Jan 18, 2017
P1, N=34, Completed, Sponsor: Vanderbilt University Medical Center
Recruiting --> Completed | N=1100 --> 796 | Trial primary completion date: Aug 2015 --> Jun 2016 Phase classification: P=N/A --> P1
- Trial completion, Enrollment change, Trial primary completion date: The Autonomic Nervous System and Obesity (clinicaltrials.gov) - Jan 18, 2017
P1, N=128, Completed, Sponsor: Vanderbilt University
Phase classification: P=N/A --> P1 Active, not recruiting --> Completed | N=288 --> 128 | Trial primary completion date: Oct 2017 --> Jan 2017
- Trial completion: Effect of Body Positioning on Upper Airway Patency During Induction of Anesthesia in Obese Patients (clinicaltrials.gov) - Jan 18, 2017
P=N/A, N=13, Completed, Sponsor: Massachusetts General Hospital
Active, not recruiting --> Completed | N=288 --> 128 | Trial primary completion date: Oct 2017 --> Jan 2017 Not yet recruiting --> Completed
- Trial primary completion date: ESTEEM - Effect of Simple, Targeted Diet in Pregnant Women With Metabolic Risk Factors on Pregnancy Outcomes (clinicaltrials.gov) - Jan 17, 2017
P=N/A, N=3442, Active, not recruiting, Sponsor: Queen Mary University of London
Not yet recruiting --> Completed Trial primary completion date: Aug 2016 --> Nov 2016
- Phase classification: The Autonomic Nervous System and Obesity (clinicaltrials.gov) - Jan 12, 2017
P1, N=288, Active, not recruiting, Sponsor: Vanderbilt University
Trial primary completion date: Aug 2016 --> Nov 2016 Phase classification: P1/2 --> P1
- Trial completion: Calcium Supplementation for a Healthy Weight-Lite (CaSHeW Lite) (clinicaltrials.gov) - Jan 10, 2017
P=N/A, N=83, Completed, Sponsor: Massachusetts General Hospital
Phase classification: P1/2 --> P1 Active, not recruiting --> Completed
- Trial primary completion date: CO-OP Trial: Community-based Outreach on Obesity in Pregnancy (clinicaltrials.gov) - Jan 6, 2017
P=N/A, N=100, Recruiting, Sponsor: University of Missouri, Kansas City
Active, not recruiting --> Completed Trial primary completion date: Dec 2016 --> Dec 2018
- Trial completion, Enrollment change: Formative Research - Developing a Family-based Obesity Prevention Intervention in the Canadian Context (clinicaltrials.gov) - Jan 5, 2017
P=N/A, N=28, Completed, Sponsor: University of Guelph
Trial primary completion date: Dec 2016 --> Dec 2018 Recruiting --> Completed | N=60 --> 28
- losartan / Generic mfg., midazolam hydrochloride / Generic mfg.
Trial completion, Trial primary completion date, Surgery, Bariatric surgery: Phenotypical Approach of the Drug Metabolizing Hormones Activity Before and After Roux-en Y-Gastric Bypass (clinicaltrials.gov) - Jan 4, 2017
P1, N=11, Completed, Sponsor: Assistance Publique - H
Recruiting --> Completed | N=60 --> 28 Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Feb 2014
- Trial suspension, Trial primary completion date: Endoscopic Suturing of the Gastric Pylorus to Delay Gastric Emptying and Treat Obesity (clinicaltrials.gov) - Dec 29, 2016
P=N/A, N=15, Suspended, Sponsor: Northwell Health
Active, not recruiting --> Completed | Trial primary completion date: Jan 2015 --> Feb 2014 Recruiting --> Suspended | Trial primary completion date: Dec 2015 --> Jun 2017
- || Trial initiation date, Trial primary completion date, Surgery, Bariatric surgery: Glucose Homeostasis Pre and Post Bariatric Surgery (clinicaltrials.gov) - Dec 28, 2016
P=N/A, N=60, Active, not recruiting, Sponsor: Washington University School of Medicine
Recruiting --> Suspended | Trial primary completion date: Dec 2015 --> Jun 2017 Initiation date: Sep 2009 --> Dec 2009 | Trial primary completion date: Sep 2016 --> Sep 2017
- | Trial completion: Behavioral Treatment for Obese Preschoolers (clinicaltrials.gov) - Dec 28, 2016
P3, N=167, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Initiation date: Sep 2009 --> Dec 2009 | Trial primary completion date: Sep 2016 --> Sep 2017 Active, not recruiting --> Completed
- Trial completion: MPOWERed Messages: Tailored Mobile Messages to Enhance Weight Loss for Teens (clinicaltrials.gov) - Dec 21, 2016
P=N/A, N=50, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial termination, Surgery, Bariatric surgery: Bariatric Surgery and Guided Self-help for Binge Eating Disorder (clinicaltrials.gov) - Dec 19, 2016
P=N/A, N=150, Terminated, Sponsor: Imperial College London
Active, not recruiting --> Completed Recruiting --> Terminated; New evidence came to light to indicate that study was no longer relevant
- Trial primary completion date: Free Fatty Acids, Body Weight, and Growth Hormones Secretion in Children (clinicaltrials.gov) - Dec 15, 2016
P1/2, N=91, Recruiting, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Recruiting --> Terminated; New evidence came to light to indicate that study was no longer relevant Trial primary completion date: Dec 2017 --> Dec 2020
- | beloranib (ZGN-440) / Larimar Therap
Trial termination: bestPWS: Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome (clinicaltrials.gov) - Dec 15, 2016
P3, N=108, Terminated, Sponsor: Zafgen, Inc.
Trial primary completion date: Dec 2017 --> Dec 2020 Active, not recruiting --> Terminated; FDA Clinical Hold
- Trial completion, Enrollment change, Trial primary completion date: Prader-Willi Syndrome Macronutrient Study (clinicaltrials.gov) - Dec 14, 2016
P=N/A, N=10, Completed, Sponsor: Duke University
Active, not recruiting --> Terminated; FDA Clinical Hold Recruiting --> Completed | N=13 --> 10 | Trial primary completion date: Sep 2016 --> May 2016
- Enrollment closed: Weight Management Intervention for Obese Women and the Live Birth Outcome of in Vitro Fertilization (IVF) (clinicaltrials.gov) - Dec 13, 2016
P=N/A, N=317, Active, not recruiting, Sponsor: Sahlgrenska University Hospital, Sweden
Recruiting --> Completed | N=13 --> 10 | Trial primary completion date: Sep 2016 --> May 2016 Recruiting --> Active, not recruiting
- Trial completion: Auricular Acupuncture in the Treatment of Obesity (clinicaltrials.gov) - Dec 12, 2016
P4, N=82, Completed, Sponsor: Mike O'Callaghan Federal Hospital
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Trial completion, Trial primary completion date, Surgery, Bariatric surgery: Bariatric Surgery, Arterial Stiffness and Target Organ Damage Study (BASTOD) (clinicaltrials.gov) - Dec 1, 2016
P=N/A, N=90, Completed, Sponsor: University Hospital, Montpellier
Active, not recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Apr 2014 --> Jan 2015
- Qsymia (topiramate/phentermine) / IEH Biopharma, Alvogen
Trial primary completion date: A Toolbox Approach to Obesity Treatment in Primary Care (clinicaltrials.gov) - Nov 29, 2016
P4, N=350, Active, not recruiting, Sponsor: Denver Health and Hospital Authority
Recruiting --> Completed | Trial primary completion date: Apr 2014 --> Jan 2015 Trial primary completion date: Jun 2016 --> Oct 2016
- Trial primary completion date: G4H-DiabNano: Video Games for Obesity and Diabetes Prevention-Diab & Nano (clinicaltrials.gov) - Nov 29, 2016
P=N/A, N=444, Recruiting, Sponsor: Baylor College of Medicine
Trial primary completion date: Jun 2016 --> Oct 2016 Trial primary completion date: Aug 2016 --> Feb 2017
- Trial completion: Fatty Acid Metabolism and Insulin Sensitivity After Exercise in Obesity (clinicaltrials.gov) - Nov 23, 2016
P=N/A, N=7, Completed, Sponsor: University of Michigan
Trial primary completion date: Aug 2016 --> Feb 2017 Active, not recruiting --> Completed